等待開盤 09-20 09:30:00 美东时间
-0.040
-2.41%
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Investor Summit Group, an inde...
09-12 01:00
Shuttle Pharmaceuticals shares fell 4.6% to $2.26 Thursday morning after earlier gains. The move lower comes despite announcing a new U.S. patent for selective histone deacetylase inhibitors.
09-05 23:18
https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12077515?requestToke[…]kYTczNGM0Ny0xZTJmLTRiZjctYTBhOC05ZDU3MWEzN2M2NzYiLCJleHAiOjB9
09-04 03:47
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with
08-28 21:02
Shuttle Pharmaceuticals (NASDAQ:SHPH) received formal notice from Nasdaq that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Quarterly Report on Form 10-...
08-27 04:19
Shuttle Pharmaceuticals (NASDAQ:SHPH) announced on Tuesday that Timothy Lorber will take over as CFO from Michael Vander Hoek. Lorber will initially serve as the company's part-time CFO until Septembe...
06-18 21:22
Shuttle Pharmaceuticals press release (NASDAQ:SHPH): At March 31, 2024, Shuttle Pharma’s cash balance was approximately $4.2 million (including cash, cash equivalents and marketable securities). More ...
05-14 22:16
Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(0.11) per share. This is a 83.33 percent decrease over losses of $(0.06) per share from the same period last year.
03-22 21:00
Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 38.8% to $0.1250 in pre-market trading. LumiraDX shares fell 25% on Monday after the company announced the receipt of the Nasdaq delisting determination.
2023-10-31 21:15
Recent Highlights Shuttle Pharma continues to execute on the necessary steps to advance Ropidoxuridine, the Company's lead clinical sensitizer drug candidate, towards the commencement of its upcoming Phase II
2023-05-26 21:02